News
Media
Academy
Conferences
Publications
CME/CE
Job Board
Subscribe
Directories

Spotlight -

Concierge Medicine Forum|

|Videos|April 15, 2021

Nancy Reau, MD: Challenges of ICD10 Coding on Patients with HE

Author(s)Nancy Reau, MD

An expert physician considers the challenges that arise with ICD10 coding in delivering care for patients with hepatic encephalopathy and risk adjustment.

Episodes in this series

EP. 1 Arun B. Jesudian, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 1 Arun B. Jesudian, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 2 Arun B. Jesudian, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 2 Arun B. Jesudian, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 3 Arun B. Jesudian, MD: Adapting Care for Outpatients with Recurrent HE

EP. 3 Arun B. Jesudian, MD: Adapting Care for Outpatients with Recurrent HE

EP. 4 Arun B. Jesudian, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 4 Arun B. Jesudian, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 5 Arun B. Jesudian, MD: Increasing Awareness of Hepatic Encephalopathy for PCP

EP. 5 Arun B. Jesudian, MD: Increasing Awareness of Hepatic Encephalopathy for PCP

EP. 6 Arun B. Jesudian, MD: Challenges of ICD10 Coding on Patients with HE

EP. 6 Arun B. Jesudian, MD: Challenges of ICD10 Coding on Patients with HE

EP. 7 Arun B. Jesudian, MD: Advice for Primary Care Physicians

EP. 7 Arun B. Jesudian, MD: Advice for Primary Care Physicians

EP. 8 Nancy Reau, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 8 Nancy Reau, MD: Physical and Economic Impact of Hepatic Encephalopathy

EP. 9 Nancy Reau, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 9 Nancy Reau, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

EP. 10 Nancy Reau, MD: Patient Care Path After HE Hospitalization

EP. 10 Nancy Reau, MD: Patient Care Path After HE Hospitalization

EP. 11 Nancy Reau, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 11 Nancy Reau, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

EP. 12 Nancy Reau, MD: Increasing HE Awareness and Comfortability for PCPs

EP. 12 Nancy Reau, MD: Increasing HE Awareness and Comfortability for PCPs

EP. 13 Nancy Reau, MD: Challenges of ICD10 Coding on Patients with HE

EP. 13 Nancy Reau, MD: Challenges of ICD10 Coding on Patients with HE

Newsletter

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Related Content

Nancy Reau, MD: Increasing HE Awareness and Comfortability for PCPs

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD: Hepatic Encephalopathy Unmet Needs and Future Developments

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD: Patient Care Path After HE Hospitalization

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD on the AASLD 2014 Practice Guidelines: Outpatient Diagnosis

ByNancy Reau, MD

April 15th 2021

Nancy Reau, MD: Physical and Economic Impact of Hepatic Encephalopathy

ByNancy Reau, MD

April 15th 2021

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

2025 state of claims: When AI tools work best

Locum tenens use up 25% amid physician shortages, $2.6M revenue gaps, CHG report finds

Early, frequent cannabis use tied to higher mental and physical health risks, McGill study finds

Spooky science; safety tips from the ACEP; the surprising health perks of Halloween – Morning Medical Update

Watch Tuesday: MFN, tariffs and a DTC push — Inside Trump’s drug-pricing reset

© 2025 MJH Life Sciences^®

All rights reserved.